Patents by Inventor Douglas H. Hoffman

Douglas H. Hoffman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Crystalline forms of kinase inhibitors
    Patent number: 8940759
    Abstract: Citrate salts of N-(4-{4-amino-7-[1-(2-hydroxyethyl)-1H-pyrazol-4-yl]thieno[3,2-c]pyridin-3-yl}phenyl)-N?-(3-fluorophenyl)urea and crystalline forms thereof are suitable pharmaceutical ingredients for pharmaceutical compositions useful in the treatment of disease, for example, cancer.
    Type: Grant
    Filed: December 16, 2013
    Date of Patent: January 27, 2015
    Inventors: Geoff G. Zhang, Douglas H. Hoffman, Jonathan M. Miller
  • CRYSTALLINE FORMS OF KINASE INHIBITORS
    Publication number: 20140296284
    Abstract: Citrate salts of N-(4-{4-amino-7-[1-(2-hydroxyethyl)-1H-pyrazol-4-yl]thieno[3,2-c]pyridin-3-yl}phenyl)-N?-(3-fluorophenyl)urea and crystalline forms thereof are suitable pharmaceutical ingredients for pharmaceutical compositions useful in the treatment of disease, for example, cancer.
    Type: Application
    Filed: December 16, 2013
    Publication date: October 2, 2014
    Inventors: Geoff G. Zhang, Douglas H. Hoffman, Jonathan M. Miller
  • Crystal forms of kinase inhibitors
    Patent number: 8633217
    Abstract: Citrate salts of N-(4-{4-amino-7-[1-(2-hydroxyethyl)-1H-pyrazol-4-yl]thieno[3,2-c]pyridin-3-yl}phenyl)-N?-(3-fluorophenyl)urea and crystalline forms thereof are suitable pharmaceutical ingredients for pharmaceutical compositions useful in the treatment of disease, for example, cancer.
    Type: Grant
    Filed: June 8, 2011
    Date of Patent: January 21, 2014
    Assignee: AbbVie Inc.
    Inventors: Geoff G. Z. Zhang, Douglas H. Hoffman, Jonathan Miller